4//SEC Filing
Roberts M Scot 4
Accession 0001104659-25-008770
CIK 0001326190other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 8:43 PM ET
Size
22.1 KB
Accession
0001104659-25-008770
Insider Transaction Report
Form 4
Roberts M Scot
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock, par value $0.0001
2025-02-01+6,166→ 69,562 total - Tax Payment
Common Stock, par value $0.0001
2025-02-02$6.64/sh−2,316$15,378→ 73,220 total - Exercise/Conversion
Restricted Stock Units
2025-02-01+6,166→ 0 total→ Common Stock, par value $0.0001 (6,166 underlying) - Exercise/Conversion
Common Stock, par value $0.0001
2025-01-30+9,275→ 62,921 total - Award
Common Stock, par value $0.0001
2025-01-31$5.18/sh+3,184$16,493→ 63,396 total - Exercise/Conversion
Common Stock, par value $0.0001
2025-02-02+7,775→ 75,536 total - Exercise/Conversion
Restricted Stock Units
2025-01-30+9,275→ 18,550 total→ Common Stock, par value $0.0001 (9,275 underlying) - Tax Payment
Common Stock, par value $0.0001
2025-02-01$6.64/sh−1,801$11,959→ 67,761 total - Exercise/Conversion
Restricted Stock Units
2025-02-02+7,775→ 7,775 total→ Common Stock, par value $0.0001 (7,775 underlying) - Tax Payment
Common Stock, par value $0.0001
2025-01-30$7.00/sh−2,709$18,963→ 60,212 total
Footnotes (7)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
- [F2]Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
- [F3]These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from August 1, 2024 through January 31, 2025.
- [F4]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 1, 2024.
- [F5]The RSUs vest in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date
- [F6]The RSUs vest in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
- [F7]The RSUs vest in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001705905
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 8:43 PM ET
- Size
- 22.1 KB